High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
about
Map the gap: missing children with drug-resistant tuberculosisOn the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia.Drug resistance of Mycobacterium tuberculosis in Malawi: a cross-sectional surveyDrug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China.Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study.Countrywide roll-out of Xpert(®) MTB/RIF in Swaziland: the first three years of implementationA Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings.Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, KenyaPerceived risk of tuberculosis infection among healthcare workers in Swaziland.Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults.Drug-resistant tuberculosis in high-risk groups, Zimbabwe.Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia.Programmatic and ethical challenges in the implementation of treatment-as-prevention in the context of HIV and drug-resistant tuberculosis co-infection in sub-Saharan Africa.Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.Rapid Microarray-based Detection of Rifampicin-, Isoniazid- and Fluoroquinolone Resistance in Mycobacterium tuberculosis using a Single Cartridge.Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
P2860
Q28547002-C172FD0F-33D6-4B52-97C1-7FB69660175DQ30873423-AE62E1AF-E521-49FB-B40E-4AC67A24B08EQ33562852-1B4590B2-70DC-4053-9733-9F6B234C512CQ34460358-4FD07148-A6E0-4547-8CE3-DC50E488C7C8Q35014534-F02C2E8A-4F6F-4CF7-BA07-2ABB480CC2F3Q35059462-42B5F0F2-0FEE-4C38-A66A-3DB45A92D2F8Q35201187-7C82C080-96E7-4C95-961D-AF7DCB41BF9CQ35212372-3CB1482C-DCBD-4BFF-98F0-CE47D3AC770DQ35584415-99FA89E4-6FB1-48C1-95AE-7AD68E99C328Q35686647-EA893391-6A63-44A4-B623-0A1F60811E28Q35804971-C15CE7D6-3589-4389-90E6-17302D30C660Q35890502-8AC6D600-A1EF-47E0-BEC2-2747A8E4CEBBQ36070976-4D1D75BF-1817-4DD3-BE8E-0F0B3298A858Q36166646-26899E5F-5537-4F1A-8E4C-873C89EBBA36Q36202796-7DE34D3C-D687-4320-808E-E5080431B244Q37002481-DD382F91-3012-4339-B33F-D0D4CF98187EQ37449060-CFB45BA6-D3D5-46DF-9402-5D4397A4E90BQ37702443-80317825-1859-4D7A-B637-8FAA0D33E7F0Q38393167-3E5ADB25-E088-471B-8672-DBF227A89F15Q40063284-932B081E-7B59-46C9-9F9F-7D8A8B131E02Q41108850-B3FB1B7F-78F8-43DE-8A12-564A5CDE13FDQ41930740-45FCDB71-4BAD-4DAE-9B9C-87CC9C2FCC2FQ47355729-469435A9-1A21-4D31-8598-F7D3F09ABECCQ52666801-21055370-5755-496F-A2C4-71AACCF2559EQ54943985-90E0D359-F436-4124-BE9E-4D56A9307C6C
P2860
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@ast
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@en
type
label
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@ast
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@en
prefLabel
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@ast
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@en
P2093
P2860
P921
P356
P1476
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
@en
P2093
Alexandra Ascorra
Elisabeth Sanchez-Padilla
Elvira Richter
Frauke Jochims
Maryline Bonnet
Philippe Calain
Roberto de la Tour
Sabine Rüsch-Gerdes
Themba Dlamini
Zerihun Demissie Tefera
P2860
P356
10.3201/EID1801.110850
P577
2012-01-01T00:00:00Z